Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boehringer ingelheim
5
×
eli lilly
life sciences
national blog main
new york blog main
5
×
new york top stories
biotech
boston blog main
boston top stories
indiana blog main
indiana top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
merck
moderna
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
biontech
deals
What
bio
companies
roundup
week
debut
drug
life
moves
science
acquisitions
approval
arena’s
bets
bid
biggest
black
boehringer
bounty
build
buy
cancer
ceo
cig
comeback
comes
company’s
continue
corner
cut
daniel
date
deal
deals
delivered
diabetes
diamond
diamond’s
dyne’s
effective
eli
Language
unset
Current search:
" boehringer ingelheim "
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines